Cryotherapy? Cryotherapy?
|
|
- Mercy Hudson
- 6 years ago
- Views:
Transcription
1 Non-Pharmacologic Therapies for Atopic Dermatitis Peter A. Lio, MD Assistant Professor Clinical Dermatology & Pediatrics Northwestern University Feinberg School of Medicine Cryotherapy? Cryotherapy? Very cold air may increase the body s antioxidative capacity Also has been shown to reduce the conduction velocity of peripheral nerves Cold may have local and systemic antiinflammatory effect relieve itch Whole-body cryotherapy in atopic dermatitis.klimenko T, Ahvenainen S, Karvonen SL.Arch Dermatol Jun;144(6): doi: /archderm. Cryotherapy? Whole-body cryotherapy has been used RA, pain, and inflammation since the 1970s The first 2 chambers are meant for precooling ( 30 C and 60 C), and the patient remains in these for a very short time. The third chamber temperature reaches 110 C, and the patient remains inside for 1 to 3 minutes wearing a bathing suit or trunks Cryotherapy? 18 adults (10 men and 8 women) with mild to moderate AD were enrolled Whole-body cryotherapy was given 3 times a week for 4 weeks Three patients had treatment-related adverse events, all mild acral frostbite! Whole-body cryotherapy in atopic dermatitis.klimenko T, Ahvenainen S, Karvonen SL.Arch Dermatol Jun;144(6): doi: /archderm. 1
2 Cryotherapy? Treatment Filaggrin filament-aggregating protein Filaggrin Mutations cause ichthyosis vulgaris (IV) 8% of eczema pts have features of IV Between 14 and 56% of eczema pts carry one or more filaggrin null mutations So: ~13% of eczema may be due to filaggrin mutations on a population scale Brown SJ, Irvine AD. Atopic eczema and the filaggrin story. Semin Cutan Med Surg Jun;27(2): Brown SJ, Irvine AD. Atopic eczema and the filaggrin story. Semin Cutan Med Surg Jun;27(2): Filaggrin IL-4 and IL-13 Irvine AD, McLean WH. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol Jun;126(6): Keratinocytes differentiated in the presence of IL-4 and IL-13 exhibited significantly reduced filaggrin gene expression Howell MD, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol Jul;120(1):
3 Topical Steroids and Barrier Either Way Danby SG, Chittock J, Brown K, Albenali LH, Cork MJ. The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis. Br J Dermatol Apr;170(4): The Barrier Problem is here to stay More Moisturizer = Less Eczema! Could moisturizers prevent eczema? Only 3/20 (15%) developed eczema Historic controls predict 6-10 should have (30-50%) Cork, et al. BJD 2003; 149: Simpson EL, Berry TM, Brown PA, Hanifin JM. A pilot study of emollient therapy for the primary prevention of atopic dermatitis. J Am Acad Dermatol Oct;63(4): The Golden Ratio Cholesterol, ceramides, and essential / nonessential free fatty acids (FFAs) in an equimolar ratio allows normal barrier recovery, whereas any 3:1:1:1 ratio of these four ingredients accelerates barrier recovery. Zettersten EM, Ghadially R, Feingold KR, Crumrine D, Elias PM. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. J Am Acad Dermatol Sep;37(3 Pt 1):
4 Moisturizer or More?? Epiceram study Clinical trial of 121 patients with moderate AD (6 months to 18 years) No statistically significant difference in efficacy between EpiCeram and fluticasone cream at day 28 At days 14 and 28, EpiCeram had comparable efficacy to fluticasone in decreasing pruritus (P >.05) POSTER ABSTRACT Pediatric Dermatology. 25(6): , November/December Sugarman, Jeffrey L. ; Eichenfield, Larry ; Simpson, Eric Moisturizer or more? Alternatives?? as good as hc 1% 4
5 CONCLUSION Moisturize well... but save your (and your patients ) money! What about bathing? Water loss is fundamental, so bathing should be important Balneotherapy is ancient, but modern practices began in Europe in the 1800s Wait! What about bathtubs? As for actual baths, such as frequency, duration, and how soon to apply moisturizers afterwards... there really is no good data! Joint Task Force Practice Parameter Update 2012: we struggled with this... 5
6 Bathtubs Although clinical trials on bathing frequency have shown mixed results, we believe that the weight of the evidence suggests that frequent soak and smear bathing is preferred to infrequent bathing in the management of AD. This simple, low-cost intervention could contribute to better AD control. Cardona ID, Stillman L, Jain N. Does bathing frequency matter in pediatric atopic dermatitis? Ann Allergy Asthma Immunol Jul;117(1):9-13. What about spa therapy? Data can be a bit messy since mineral water baths also involve: Warm weather (climatotherapy) Sunshine (heliotherapy) A vacation setting (relaxation) Balneotherapy There is solid data that children and adults with moderate-to-severe AD generally improve with balneotherapy/spa therapy But it s: Expensive Time-consuming Temporary Ahhhh... Treatment 6
7 Dilute Bleach baths Bleach: How does it work? Randomized placebo-controlled trial of 31 children with moderate-to-severe eczema All received oral antibiotics Half got intranasal mupirocin + dilute bleach bath; other half got vaseline nasally and placebo bleach bath Significant decrease in severity of eczema at 1 mo and 3 mo Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics May;123(5):e It is probably anti-inflammatory 2. It probably has limited effect on the bacteria in the way that it is actually used: After TCS + bleach bath or TCS alone, bacterial compositions on lesional skin normalized (P <.0001), resembling nonlesional skin, with microbial diversity restored to control skin levels. HOCl attenuates acute radiation dermatitis Gonzalez ME et al. J Am Acad Dermatol Sep;75(3): e8 Leung TH, Zhang LF, Wang J, Ning S, Knox SJ, Kim SK. Topical hypochlorite ameliorates NF-κBmediated skin diseases in mice. J Clin Invest Dec;123(12):
8 3. It may be via TEWL and itch reduction: This study suggests that the benefit observed with bleach baths is likely mediated by improvement in skin barrier function (TEWL and SC cohesion) and reduction in itch intensity but not in normalization of the skin microbiome or systemic Th2 inflammation. Anti-bacterial Clothing? Specialized silk garments with antimicrobial properties have been studied in eczema Perez-Nazario N, et al. Bleach baths significantly reduce itch and severity of atopic dermatitis with no significant change in S. aureus colonization and only modest effects on skin barrier function. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2016, May. Vol. 135, pp. S37-S37. Anti-bacterial Clothing? 2007: 22 children with AD were divided into specialized silk clothing vs. cotton control At weeks 4, 8, and 12 significant decrease in SCORAD was found in the silk group Possibly works by aiding wound healing, enhancing collagen synthesis, and reducing inflammation and bacteria Koller DY, Halmerbauer G, Böck A, Engstler G. Action of a silk fabric treated with AEGIS in children with atopic dermatitis: a 3-month trial. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2007;18: Silky smooth? 15 pts with AD had split garments: cotton/silk On the cotton side they were allowed to use topical corticosteroids, but not on the silk side At day 7, no difference between the sides (suggesting that silk is as good as a topical steroid!) Senti G, Steinmann LS, Fischer B, Kurmann R, Storni T, Johansen P, et al. Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatment. Dermatology (Basel, Switzerland). 2006;213: Silky smooth? Exciting! BUT... A 2009 review pointed out that all of the studies were underpowered to make such claims and cautioned skepticism... Silver Several silver-coated textiles have also been studied Do have true antibactieral effect on staph Several studies have found significant improvement in eczema and pruritus 8
9 Treatment Phototherapy PHOTOTHERAPY 1903 Nobel Prize in Medicine: Niels Ryberg Finsen, Danish pioneer of phototherapy Om Lysets Indvirkninger paa Huden (On the effects of light on the skin) Probably multiple mechanisms including increasing vitamin D which in turn enhances cathelicidin Phototherapy Works in about 60% of refractory cases NB-UVB (311 nm) seems fairly safe Problems: Time Money (co-pays, parking, etc) Home units? 9
10 Vitamin D Vitamin D 11 children (mean age, 7 years) w/ AD that worsened in winter Randomly given 1000 IU of D2 or placebo qd x 1 mo Otherwise normal regimen Sidbury R, Sullivan AF, Thadhani RI, Camargo CA Jr. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol Jul;159(1): Sidbury R, Sullivan AF, Thadhani RI, Camargo CA Jr. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol Jul;159(1): Vitamin D Final Word? Corroborating study: 37 children 8 mo-12 yr with AD Serum 25(OH)D levels correlated significantly (inversely) with disease severity Higher D correlated with less severity Peroni DG, Piacentini GL, Cametti E, Chinellato I, Boner AL.Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol May;164 This meta-analysis showed that serum vitamin D level was lower in the AD patients and vitamin D supplementation could be a new therapeutic option for AD. Kim MJ, Kim SN, Lee YW, Choe YB, Ahn KJ. Vitamin D Status and Efficacy of Vitamin D Supplementation in Atopic Dermatitis: A Systematic Review and Meta-Analysis. Nutrients, 2016 Dec 3;8(12). pii: E789 FOOD ALLERGY AND AD: Is it a cause? Is it a trigger? Is it unrelated? Treatment -R. Sidbury, MD Moisturization 10
11 Antipruritics Very poor data for antihistamines (though we often use them, esp for sedation) Topicals are unsatisfying (camphor, menthol, pramoxine) Gabapentin, TCAs, SSRIs, even antipsychotics have been tried (olanzapine) ANTIPRURITICS 40 pts with refractory uremic pruritus randomized to: Unilateral Quchi (LI11) acupuncture 3x/wk x 1 mo Control was acupuncture to sham point 3x/wk x 1 mo Pruritus scores at baseline, 1 mo and 3 mo Significantly lower in acupuncture group at 1 and 3 months (P<0.001) Acupressure 15 adults, with moderate-severe eczema Half applied acupressure with small bead in LI11 point for 3 min 3x per week for 4 weeks Che-Yi C, Wen CY, Min-Tsung K, Chiu-Ching H. Acupuncture in haemodialysis patients at the Quchi (LI11) acupoint for refractory uraemic pruritus. Nephrol Dial Transplant Sep;20(9): Acupressure Hypnosis and Biofeedback Stress can worsen AD and directly slows healing skin barrier (Muizzuddin, 2003) Psychosocial stress and sleep deprivation disrupt skin barrier function in healthy patients (Altemus, 2001) Some forms of alt med may help AD by decreasing stress, something that we have limited options for in allopathic medicine 11
12 Hypnosis Study:18 adults and 20 children with severe, resistant atopic dermatitis treated with hypnotherapy Significant benefit found both subjectively and objectively, maintained up to 2 years in some patients 10/12 children at 18 months after the study reported continued improvement in itching and scratching, less sleep disturbance, and improvement in mood Hypnosis What is Eczema Boot Camp? An intensive daily regimen for patients with severe eczema to get their eczema back under control The regimen consists of the following treatments at least once daily: 10-minute bleach bath Topical therapy (application of a topical antiinflammatory agent, generally a mid-potency topical corticosteroid) Emollient application (applied on top of the antiinflammatory agent)** Wet wraps **Topical therapy followed by emollient application should be done twice daily. Wet Wraps 12
13 Study 37 adult patients or caregivers 19 in control group = Verbal Instruction (VI) only 18 in intervention group = written Eczema Action Plan (EAP) given Pre- and Post-education questionnaires given Results Find out more: The written EAP was better than the verbal instruction in terms of: Reducing anxiety about the plan (p<.01) Increasing understanding of: The treatment regimen (p=.02) The risks/benefits of the treatments (p=.02) Adjusting the medications based on disease severity and anatomic site (p<.01, p=.03) Shi VY, Nanda S, Lee K, Armstrong AW, Lio PA. Improving patient education with an eczema action plan: a randomized controlled trial. JAMA Dermatology (March). 13
14 Thank you! 14
2/25/17. Translating the Evidence: Allergy vs. Dermatology. How can they disagree?! Bias: It doesn t come out in the wash. wash. Precision Medicine
Translating the Evidence: Allergy vs. Dermatology Peter A. Lio, MD, FAAD Assistant Professor Clinical Dermatology & Pediatrics Northwestern University Feinberg School of Medicine How can they disagree?!
More information5007 Seminar Advanced Therapeutics: Managing Severe & Refractory Eczema. Part 1. Keys to Adherence: Simplify regimen & Educate
5007 Seminar Advanced Therapeutics: Managing Severe & Refractory Eczema Luz Fonacier, MD Professor of Clinical Medicine State University of New York at Stony Brook Head of Allergy & Training Program Director
More informationF036-Controversies in Vitamin D VITAMIN D AND ATOPIC DERMATITIS. Tissa Hata M.D. Professor, UCSD Department of Dermatology
F036-Controversies in Vitamin D VITAMIN D AND ATOPIC DERMATITIS Tissa Hata M.D. Professor, UCSD Department of Dermatology DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Tissa Hata M.D. F036-Controversies in
More informationHow Should We Handle Them?
Alternative and Complementary Therapies: How Should We Handle Them? Peter A. Lio, MD Assistant Professor Clinical Dermatology & Pediatrics Northwestern University Feinberg School of Medicine DISCLOSURE
More informationBiologic Therapies for Atopic Dermatitis and Beyond
Biologic Therapies for Atopic Dermatitis and Beyond Jonathan Corren, M.D. Departments of Medicine and Pediatrics, David Geffen School of Medicine at UCLA Disclosures Genentech - research Medimmune/AZ -
More informationWhat s Topical About Topicals?
What s Topical About Topicals? Megha M. Tollefson, MD Associate Professor of Dermatology and Pediatrics July 29, 2017 2015 MFMER 3513105-1 Disclosures None 2015 MFMER 3513105-2 Outline Topical steroids
More informationBarrier Function and Microbiotic Dysbiosis in Atopic Dermatitis. Mike Levin Division of asthma and allergy Department of paediatrics
Barrier Function and Microbiotic Dysbiosis in Atopic Dermatitis Mike Levin Division of asthma and allergy Department of paediatrics Eczema / dermatitis is an inflammatory skin reaction Atopic Phototoxic
More informationAssessing the Current Treatment of Atopic Dermatitis: Unmet Needs
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationUPDATES IN ATOPIC DERMATITIS
UPDATES IN ATOPIC DERMATITIS Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute, Scottsdale, AZ LEARNING OBJECTIVES Discuss epidemiology, risk factors, and causes of
More informationAn Update on Topical Therapy for Atopic Dermatitis
An Update on Topical Therapy for Atopic Dermatitis Amy S. Paller, M.D. Professor and Chair of Dermatology Professor of Pediatrics Northwestern University Feinberg School of Medicine Chicago, Illinois Disclosures
More informationManaging Atopic Derma00s: Itching the Night Away. Karol Timmons RN, MS, CPNP Boston Children s Hospital Atopic Derma00s Center
Managing Atopic Derma00s: Itching the Night Away Karol Timmons RN, MS, CPNP Boston Children s Hospital Atopic Derma00s Center Learning Objec-ves Describe common treatments for atopic derma00s including:
More informationApproach to eczema. Hugo Van Bever Department of Pediatrics NUHS - Singapore
Approach to eczema Hugo Van Bever Department of Pediatrics NUHS - Singapore APAPARI workshop, Yangon, October 30, 2016 Eczema in children 1. Atopic dermatitis 2. Constitutional eczema 3. Contact dermatitis
More informationUpdate on emollients
Update on emollients Amal Mhanna, MD Pediatric Dermatologist Clemenceau Medical Center Disclosure: I was a member of an advisory board y for J&J and received honoraria. Emollients and moisturizers are
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationOverview. Atopic Dermatitis. Overview. 1. Genes and pathogenesis 2. Natural history and disease course 3. Comorbidities 4. Treatments 5.
Overview Atopic Dermatitis Albert C. Yan, MD, FAAP, FAAD Children s Hospital of Philadelphia Perelman School of Medicine at the University of Pennsylvania 1. Genes and pathogenesis 2. Natural history and
More informationWhat is atopic dermatitis?
What is atopic dermatitis? Complex inflammatory skin disorder intense pruritus cutaneous hyperreactivity immune dysregulation Chronic with exacerbations and remissions Affects all ages, but more common
More informationRecent insights into atopic dermatitis and implications for management of infectious complications
Mark Boguniewicz, MD Professor, Division of Allergy-Immunology Department of Pediatrics National Jewish Health and University of Colorado School of Medicine Denver, Colorado USA Recent insights into atopic
More informationLearning Circle: Jan 26, 2011 Childhood Eczema
Learning Circle: Jan 26, 2011 Childhood Eczema Wingfield Rehmus, MD MPH BC Children s Hospital Clinical Assistant Professor, UBC Department of Paediatrics Associate Member, UBC Department of Dermatology
More informationLearning Objectives 10/26/2017. New Treatments in Atopic Dermatitis
New Treatments in Atopic Dermatitis Lynda C. Schneider, MD Professor of Pediatrics, Harvard Medical School Boston Children s Hospital lynda.schneider@childrens.harvard.edu Disclosures: Lynda Schneider,
More informationAtopic Eczema with detail on how to apply wet wraps
Atopic Eczema with detail on how to apply wet wraps Dr Carol Hlela Consultant Dermatologist Head of Unit, Department of Dermatology, Paediatrics Red Cross Children s Hospital, UCT Red Cross War Memorial
More informationComparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis
Original Article Comparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis Md Alauddin Khan *, Lubna Khondker **, Dilshad
More informationBeacon Hospital Annual Study Morning Treatment of Atopic Dermatitis (Eczema) in Primary Care
Beacon Hospital Annual Study Morning Treatment of Atopic Dermatitis (Eczema) in Primary Care Alan D. Irvine MD DSc Lecture overview What causes AD How to get optimise results in primary care Eczema and
More informationMarch 9, 2015 From: The Pediatric Dermatology Research Alliance (PeDRA)
Web: www.pedraresearch.org From: The Pediatric Dermatology Research Alliance (PeDRA) To: Jennifer Shepherd, Center for Drug Evaluation and Research Food and Drug Administration, 10903 New Hampshire Ave.,
More information15 minute eczema consultation
THERAPY WORKSHOP 15 minute eczema consultation History Current treatments Examination Treatment Plan Written action plan Soap substitute/bath oil Antiseptic baths Emollients Topical steroids Other treatments
More informationItchy babies: Current treatment guidelines for atopic dermatitis
Itchy babies: Current treatment guidelines for atopic dermatitis Rachel Laarman, MD Helen DeVos Children s Hospital Grand Rapids, MI Photo cred: www.dermatologytimes.modernmedicine.com I have no disclosures
More informationLessons Learned from the International Eczema Council (IEC)
Lessons Learned from the International Eczema Council (IEC) Amy S. Paller, MD Northwestern University Feinberg School of Medicine American Academy of Dermatology meeting F046 February 17, 2017 No conflicts
More informationProfessor Rohan Ameratunga Clinical Immunologist and Allergist Auckland
Professor Rohan Ameratunga Clinical Immunologist and Allergist Auckland 16:30-17:25 WS #170: Eczema Management 17:35-18:30 WS #182: Eczema Management (Repeated) Managing ECZEMA A/Prof Rohan Ameratunga
More informationSkin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist
Skin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist I have no conflicts of interest 6 yo boy referred for AD. On topical HC and food elimination diet s/p topical triamcinolone to body
More informationTRIGGERS & TREATMENT OF ATOPIC DERMATITIS COA#PCIA0809 CE Activity provided by PCI Journal
TRIGGERS & TREATMENT OF ATOPIC DERMATITIS COA#PCIA0809 CE Activity provided by PCI Journal INSTRUCTIONS 1. Read the article. 2. Take the test, record your answers in the test answer section (Section B)
More informationCholestatic jaundice Chronic kidney disease Iron deficiency +/-anaemia. Hepatoma Diabetes Leukaemia
Pruritis Introduction Pruritis can cause discomfort, frustration, poor sleep, anxiety and depression. Itch may be localised or due to systemic disease. Pruritis in systemic disease is often worse at night.
More informationAtopic Dermatitis. Atopic dermatitis (AD) is very common with a. Going Skin Deep With. Carl s rashes
Focus on CME at Dalhousie University Going Skin Deep With Atopic Dermatitis Scott Murray, MD, FRCP(C), BSc Atopic dermatitis (AD) is very common with a tendency for itching and inflammation of the skin.
More informationHot topics in Pediatric Dermatology. Yvonne Chiu, MD
Hot topics in Pediatric Dermatology Yvonne Chiu, MD Hot Topics for Pediatric Dermatology Yvonne Chiu, MD WDS Summer Meeting July 21, 2012 Disclosure Statement I, Yvonne Chiu, MD, do not have any relevant
More informationRELEVANT DISCLOSURES ATOPIC DERMATITIS / ECZEMA MANAGING ECZEMA IN INFANTS AND CHILDREN
RELEVANT DISCLOSURES MANAGING ECZEMA IN INFANTS AND CHILDREN Advisory board member - MEDA (Elidel), Speaking honoraria Bayer (Advantan) Advisory board, consultant, speaker: Pfizer, Abbvie, Janssen, Elli
More informationMedication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018
Independent licensees of the Blue Cross and Blue Shield Association Medication Policy Manual Policy No: dru493 Topic: Dupixent, dupilumab Date of Origin: March 10, 2017 Committee Approval: March 10, 2017
More informationNovel Insights in Atopic Dermatitis: Pathways, Biomarkers, and Phenotypes for a Targeted Approach Transcript
Novel Insights in Atopic Dermatitis: Pathways, Biomarkers, and Phenotypes for a Targeted Approach Transcript Title Slide Welcome to the CME-certified program: Novel Insights in Atopic Dermatitis; Pathways,
More informationPharmacologic Treatment of Atopic Dermatitis
J KMA Pharmacotherapeutics Pharmacologic Treatment of Atopic Dermatitis Chun Wook Park, MD Department of Dermatology, Hallym University College of Medicine E mail : dermap@paran.com J Korean Med Assoc
More informationWhite Rose Research Online URL for this paper:
This is an author produced version of Vitamin D and antimicrobial peptide levels in patients with atopic dermatitis and atopic dermatitis complicated by eczema herpeticum: A pilot study.. White Rose Research
More informationSerum Vitamin D Levels Not Associated with Atopic Dermatitis Severity
Pediatric Dermatology Vol. 33 No. 3 283 288, 2016 Serum Vitamin D Levels Not Associated with Atopic Dermatitis Severity Renata Robl, M.D., Marjorie Uber, M.D., Kerstin Taniguchi Abagge, M.D., Monica Nunes
More informationAtopic Dermatitis Guidelines: What s New?
Atopic Dermatitis Guidelines: What s New? Lawrence F. Eichenfield, M.D. Professor of Dermatology and Pediatrics University of California, San Diego Rady Children s Hospital, San Diego Anacor/Pfizer Genentech
More informationIntroduction to the Aron Regimen for the treatment of atopic eczema
Introduction to the Aron Regimen for the treatment of atopic eczema PREPARED BY A GROUP OF PATIENTS AND PARENTS OF PATIENTS OF DR RICHARD ARON, CONSULTANT DERMATOLOGIST JULY 2017 Who is Dr Richard Aron
More informationThe Burden of Atopic Dermatitis: from Population to Bedside
The Burden of Atopic Dermatitis: from Population to Bedside S028 AAD Annual Meeting March 2, 2019 Research and institutional funding Sanofi Regeneron Disclosures Consultant Honoraria Sanofi Astellas Canada
More informationMicrobes and atopic dermatitis: The Yin and Yang of barrier and immune dysfunction
Hong Kong J. Dermatol. Venereol. (2016) 24, 17-23 Review Article Microbes and atopic dermatitis: The Yin and Yang of barrier and immune dysfunction Atopic dermatitis (AD) is a chronic, inflammatory skin
More informationManaging Eczema. Eczema Education Series.
Managing Eczema Eczema Education Series www.eczemahelp.ca Table of Contents Introduction to Eczema Triangle of Control 1 2 Education What is Eczema? What Causes Eczema? Understanding the Disease Impaired
More informationWYNNIS L. TOM, MD: And I m Dr. Wynnis Tom. I m Associate Professor of Dermatology and Pediatrics at the University of California, San Diego.
LEARNING OBJECTIVES At the conclusion of this activity, participants should be better able to: Assess the severity of atopic dermatitis (AD) and its impact on the patient Evaluate treatment efficacy Design
More informationProactive Therapy and Emollient Therapy in Atopic Dermatitis
Current Treatment Options in Allergy (2014) 1:365 373 DOI 10.1007/s40521-014-0036-7 Atopic Dermatitis (A Wollenberg, Section Editor) Proactive Therapy and Emollient Therapy in Atopic Dermatitis A. P. Oranje,
More informationAtopic Dermatitis. Kong-Sang Wan, MD, PhD 温港生醫師台北市聯合醫院仁愛院區小兒科
Atopic Dermatitis Kong-Sang Wan, MD, PhD 温港生醫師台北市聯合醫院仁愛院區小兒科 Introduction A chronic inflammatory skin disease associated with cutaneous hyperreactivity to environmental triggers influenced by bacterial
More informationAtopic Dermatitis: Therapeutic Challenges
Atopic Dermatitis: Therapeutic Challenges PDA August 14, 2009 Jon Hanifin OHSU, Portland Dominant Concepts in Atopic Dermatitis Allergy / Immunology Era: 1915-2006 The Epidermal Era: 2006---- Barrier dysfunction
More informationTopical Immunomodulator Step Therapy Program
Topical Immunomodulator Step Therapy Program Policy Number: 5.01.557 Last Review: 8/2017 Origination: 7/2013 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) BCBSKC will provide
More informationThe lipid barrier of the Stratum Corneum
The lipid barrier of the Stratum Corneum Stratum Corneum: the "Bricks and Mortar" model Ceramides (40-65% total lipids) HN O Glucoceramides HN O O HO O cerabrosidase Cholesteryl sulphate Free fatty acids
More informationThe hands in health and disease of individuals with filaggrin loss-of-function mutations: clinical reflections on the hand eczema phenotype
Contact Dermatitis Review Article COD Contact Dermatitis The hands in health and disease of individuals with filaggrin loss-of-function mutations: clinical reflections on the hand eczema phenotype Jeanette
More informationMolecular mechanisms in atopic eczema - why do they ma6er in the clinic?
Molecular mechanisms in atopic eczema - why do they ma6er in the clinic? Sara Brown Professor of Molecular & Gene0c Dermatology Wellcome Trust Senior Fellow in Clinical Research Professor of Molecular
More informationNitric Oxide-Releasing Topical Therapeutic for Atopic Dermatitis
Nitric Oxide-Releasing Topical Therapeutic for Atopic Dermatitis K. McHale 1, J. Gil 2, S. Davis 2, S. Hollenbach 1, and N. Stasko 1 1 Novan, Inc., Morrisville, NC; 2 Department of Dermatology and Cutaneous
More informationAn Everyday Guide to Eczema
An Everyday Guide to Eczema By Dr. Kristel Polder, Board-Certified Dermatologist Developed in Partnership with Who is affected by eczema? 32 million people in the US 1 in 5 children 1 in 12 adults *www.eczema.org
More informationFaculty Information ECZEMA: THE ITCH THAT RASHES 2/13/2015. Disclosures and COI Resolution. Pharmacy Accreditation
Faculty Information ECZEMA: THE ITCH THAT RASHES A CONTINUING EDUCATION WEBINAR Speaker Celia Lu, Pharm.D, BCACP Assistant Clinical Professor St. John s University College of Pharmacy & Health Sciences
More informationExpert Analysis of Emerging Atopic Dermatitis Therapy Studies. A CE/CME Activity
Expert Analysis of Emerging Atopic Dermatitis Therapy Studies Overview A CE/CME Activity Lawrence F. Eichenfield, MD, and Jonathan I. Silverberg, MD, PhD, MPH, provide their perspectives on the clinical
More informationNovan Announces Promising Clinical Results with SB414
Novan Announces Promising Clinical Results with SB414 In the recently completed Phase 1b trial for atopic dermatitis, clinical efficacy measures were highly correlated with critical and disease-relevant
More informationThe Itch That Rashes. Sarah D. Cipriano, MD, MPH, MS Resident, Dermatology University of Utah
The Itch That Rashes Sarah D. Cipriano, MD, MPH, MS Resident, Dermatology University of Utah 1 Conflict of Interest No conflict of interest Will discuss off label use of medications 2 3 Most likely diagnosis?
More informationNovan Provides Update on SB414 Inflammatory Skin Disease Development Program
Novan Provides Update on SB414 Inflammatory Skin Disease Development Program SB414 Nitric Oxide-Releasing Cream Safe and Well-Tolerated in Psoriasis Phase 1b Trial Preclinical Data with SB414 Targeting
More informationUpdates in the Management of Epidermal Growth Factor Receptor (EGFR) Inhibitors- Induced Skin Rash. Outline. Signal Transduction
Updates in the Management of Epidermal Growth Factor Receptor (EGFR) Inhibitors- Induced Skin Rash Siu-Fun Wong, PharmD, FASHP, FCSHP Associate Professor of Pharmacy Practice Western University of Health
More informationEucrisa. Eucrisa (crisaborole) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Eucrisa Page: 1 of 7 Last Review Date: June 22, 2018 Eucrisa Description Eucrisa (crisaborole)
More informationFollow this and additional works at: Part of the Medicine and Health Sciences Commons
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2018 Does coconut oil aid in improving the
More informationVitamina D: un ormone multifunzione
Vitamina D: un ormone multifunzione Introduction And Infections Diego Peroni Clinica Pediatrica Universita di Ferrara Food Allergy Asthma Conclusions diego.peroni@unife.it Holick, M. F. J. Clin. Invest.
More informationTexas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD)
Diagnosis: ATOPIC DERMATITIS (AD) Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD) PATIENT ADVICE: Unfortunately, there is no cure for atopic dermatitis, so
More informationDose-dependent effects of tobramycin in an animal model of Pseudomonas sinusitis Am J Rhino Jul-Aug; 21(4):423-7
AMINOGLYCOSIDES Dose-dependent effects of tobramycin in an animal model of Pseudomonas sinusitis Am J Rhino. 2007 Jul-Aug; 21(4):423-7 http://www.ncbi.nlm.nih.gov/pubmed/17882910 Evaluation of the in-vivo
More informationStudy. Kunal J. Khobragade GlaxoSmithKline Pharmaceuticals Ltd., Mumbai, India
Study Efficacy and safety of combination ointment fluticasone propionate 0.005% plus mupirocin 2.0% for the treatment of atopic dermatitis with clinical suspicion of secondary bacterial infection: An open
More informationEichenfield: Neonatal Dermatology
What You Need to Know about Pediatric Dermatology Lawrence F. Eichenfield, M.D. Professor of Dermatology and Pediatrics University of California, San Diego Rady Children s Hospital, San Diego Disclosures
More informationDupilumab and Crisaborole for Atopic Dermatitis: Effectiveness, Value, and Value-Based Price Benchmarks
Dupilumab and Crisaborole for Atopic Dermatitis: Effectiveness, Value, and Value-Based Price Benchmarks Draft Background and Scope November 7, 2016 Background: Atopic dermatitis (eczema) is a chronic/chronically-relapsing
More informationContact Dermatitis In Atopic Patients
Contact Dermatitis In Atopic Patients Jenny Murase, MD Palo Alto Foundation Medical Group Director of Patch Testing University of California, San Francisco Associate Clinical Professor Disclosures Consultant
More informationA Child with Eczema: A Parent s Guide
A Child with Eczema: A Parent s Guide What is eczema? Originally the term eczema was used to describe any itchy rash that blistered; now eczema describes skin which is red (inflamed) and intensely itchy.
More informationCanola oil and hempseed oil for atopic dermatitis skin treatment
Canola oil and hempseed oil for atopic dermatitis skin treatment Carmen Vincent, MD, PhD Dr Carmen Vincent Clinic of General and Aesthetic Dermatology Dr Irena Eris Cosmetic Laboratories, Centre for Science
More informationECZEMA SOCIETY OF CANADA ATOPIC DERMATITIS: PATIENT INSIGHTS REPORT MILD-TO-MODERATE DISEASE
ECZEMA SOCIETY OF CANADA ATOPIC DERMATITIS: PATIENT INSIGHTS REPORT MILD-TO-MODERATE DISEASE 1 OVERVIEW OF SURVEY RESULTS INTRODUCTION PATIENT INSIGHTS BY THE NUMBERS: Adult Atopic Dermatitis (AD) In the
More informationEucrisa. Eucrisa (crisaborole) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.25 Subject: Eucrisa Page: 1 of 6 Last Review Date: September 15, 2017 Eucrisa Description Eucrisa
More informationA Pilot Study. Name of investigational product:
An Open Label, Multi Center Clinical Study to Evaluate the Efficacy and Safety of a New Topical Cosmeceutical in Relieving the Redness, Scaling and Flaking Associated with Severe Skin Conditions A Pilot
More informationManaging Eczema. Eczema Education Series.
Managing Eczema Eczema Education Series www.eczemahelp.ca EDUCATION Table of Contents Education What is Eczema? What Causes Eczema? Understanding the Disease Impaired Skin Barrier Function Flare-Ups Trigger
More informationThe Role of Allergen Immunotherapy and Biologicals in the Treatment of Atopic Dermatitis
The Role of Allergen Immunotherapy and Biologicals in the Treatment of Atopic Dermatitis John Oppenheimer MD Div Allergy and Immunology UMDNJ-Rutgers Potential Conflicts of Interest Consultant GSK, Teva,
More informationRELEVANT DISCLOSURES. Consultant for Galderma Research grant from Ceragenix Investigator on Novartis study Research grant from Celgene
Novel Therapeutics in Atopic Dermatitis Eric Simpson, MD,MCR Associate Professor, Dermatology Oregon Health & Science University RELEVANT DISCLOSURES Consultant for Galderma Research grant from Ceragenix
More informationVITAMIN D AND THE SKIN JOYCE FARAH MD MS FAAD FARAH DERMATOLOGY AND COSMETICS, LLC ASSISTANT PROFESSOR OF MEDICINE AND ENT UPSTATE MEDICAL UNIVERSITY
VITAMIN D AND THE SKIN JOYCE FARAH MD MS FAAD FARAH DERMATOLOGY AND COSMETICS, LLC ASSISTANT PROFESSOR OF MEDICINE AND ENT UPSTATE MEDICAL UNIVERSITY VIT D RECEPTORS ROLE IN MAINTAINING NORMAL FOLLICULAR
More informationThe safety and effectiveness of Dupixent in pediatric patients have not been established (1).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.30 Subject: Dupixent Page: 1 of 6 Last Review Date: September 15, 2017 Dupixent Description Dupixent
More informationPRODUCT DATA SHEET. Updated: 07/2012 Approved: Dr. Victoria Donat
PRODUCT DATA SHEET is a Refined Vegetable Oil composition enriched with other ingredients and specifically developed to enhance anti stretch activity. The composition helps to prevent and eliminate stretch
More information8-year surveillance 2016 Atopic eczema in under 12s (2007) NICE guideline CG57
8-year 2016 Atopic eczema in under 12s (2007) NICE guideline CG57 Appendix A: decision matrix year Diagnosis 57 01 What criteria should be used to diagnose atopic eczema in children and how do they vary
More informationDr David Orchard MBBS FACD
Eczema Dr David Orchard MBBS FACD What is eczema? Eczema is a particular type of inflammatory reaction in the skin. The features include redness, scaling and itch. When it is more severe the skin will
More information45 min. Name Assoc Prof presenter Bill McGuiness PhD, RN, FAWMA. xx College Month of 201x Science, Health & Engineering
45 min Title Skin integrity of presentation the cellular level? Name Assoc Prof presenter Bill McGuiness PhD, RN, FAWMA Title Head of of presenter School School / of Faculty Nursing / Division & Midwifery
More informationNORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING FOR GENERAL PRACTICE
AUGUST 2011 PRESCRIPTION COMPOUNDING N ORLANDA VENUEP HARMACY. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Hemorrhoids 2 Celiac Disease 3 PRESCRIPTION
More informationWhat snewin atopicdermatitis. Dagmar Simon Universitätsklinik für Dermatologie, Inselspital, Universitätsspital Bern
What snewin atopicdermatitis Dagmar Simon Universitätsklinik für Dermatologie, Inselspital, Universitätsspital Bern Impairedskinbarrierand Th2 inflammation Environment CD4, CD8 IL-4 IL-5 IL-13 IFN-γ DC
More informationIAD and its Severity Instrument
IAD and its Severity Instrument Designed and validated by WOC nurses and their faculty 2 WOC nurses established initial face validity Content and criterion validity via 9 WOC nurses in North Central Region
More informationCOMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio
COMMON SKIN CONDITIONS IN PRIMARY CARE Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio DISCLOSURE The Speaker and members of the planning committee do not have a conflict of interest
More informationDermatology elective for yr. 5. Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015
Dermatology elective for yr. 5 Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015 How to diagnosis and manage eczema and psoriasis. Objectives
More informationCommon Side Effects. Fatigue Neuropathy Hot flashes
Common Side Effects Fatigue Neuropathy Hot flashes Fatigue According to the National Comprehensive Cancer Network (2017), cancer related fatigue is defined as a distressing, persistent, subjective sense
More informationDermaPep A530. Multifunctional anti-inflammatory peptide for irritated and sensitive skin. Experience The Magic of Science
Experience The Magic of Science DermaPep A53 Multifunctional anti-inflammatory peptide for irritated and sensitive skin DermaP ep Experience the magic of science Anti-aging DermaPep A35 DermaPep A42 DermaPep
More informationWhat s New in Atopic Dermatitis?
What s New in Atopic Dermatitis? SMITA AWASTHI, MD ASSISTANT CLINICAL PROFESSOR, DEPT. OF DERMATOLOGY AND PEDIATRICS UNIVERSITY OF CALIFORNIA, DAVIS Disclosures No financial disclosures relevant to this
More informationPediatric Dermatology. Dra. Ana Batalla
Pediatric Dermatology Dra. Ana Batalla Special aspects of skin in neonates and infants Prof. Dr. Regina Fölster-Holst. Kiel - Germany. Vernix caseosa facilitates the development of stratum corneum Functions
More informationFinal Program. 9 th Georg Rajka ISAD Program - Thursday, May 19, 2016 at the Renaissance São Paulo Hotel Theater
Final Program Program - Thursday, May 19, 2016 at the Renaissance São Paulo Hotel Theater Theme / Lecture Speaker / Country Time schedule Prologue: "My Adorable Son" Verônica SARNO (Brazil) 14:00-14:05
More informationLawrence F. Eichenfield, M.D.
What s New in Pediatric Dermatology Lawrence F. Eichenfield, M.D. Professor of Dermatology and Pediatrics Rady Children s Hospital, San Diego University of California, San Diego Disclosure Lawrence F.
More informationDietary Supplements: Safe, Effective or Neither?
Dietary Supplements: Safe, Effective or Neither? KEEP YOUR EDGE Hockey Sports Medicine 2015 August 28, 2015 Dr. Ashley James, B.A., N.D. Naturopathic Doctor Disclosure I have no relevant non-financial
More informationATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP
ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP Disclosures Promotional Speaker for Pfizer, Inc. Any unlabeled/unapproved uses of drugs or products
More informationDAILY CARE FOR DRY, IRRITATED AND REACTIVE SKIN. Physiogel A.I. Help your patients restore skin balance and well-being
DAILY CARE FOR DRY, IRRITATED AND REACTIVE SKIN Help your patients restore skin balance and well-being Dry, irritated and reactive skin a question of balance Changes in the lipid barrier (1) Neurological
More informationAn Update on Atopic Dermatitis
An Update on Atopic Dermatitis Mark Boguniewicz, MD Professor, Division of Allergy-Immunology Department of Pediatrics National Jewish Health and University of Colorado School of Medicine Disclosures for
More informationDermatology Literary Review
Emollients and ageing skin: optimising effectiveness and safety of Nursing, Vol. 25, No.11, pages 596-598. 6 Article outlines the causes of dryness in ageing skin and concludes that emollients are the
More informationVitiligo is a skin depigmentation disorder
THERPEUTICS FOR THE CLINICIN Tacrolimus Ointment 0.1% Produces Repigmentation in Patients With Vitiligo: Results of a Prospective Patient Series Emil. Tanghetti, MD The cause of the selective melanocyte
More information